NovoCure Ltd Annual Cost of Revenue in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
NovoCure Ltd quarterly/annual Cost of Revenue history and growth rate from 2013 to 2023.
  • NovoCure Ltd Cost of Revenue for the quarter ending September 30, 2024 was $35.4M, a 10.2% increase year-over-year.
  • NovoCure Ltd Cost of Revenue for the twelve months ending September 30, 2024 was $136M, a 9.36% increase year-over-year.
  • NovoCure Ltd annual Cost of Revenue for 2023 was $128M, a 11.7% increase from 2022.
  • NovoCure Ltd annual Cost of Revenue for 2022 was $115M, a 0.01% decline from 2021.
  • NovoCure Ltd annual Cost of Revenue for 2021 was $115M, a 7.87% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $128M +$13.4M +11.7% Jan 1, 2023 Dec 31, 2023 10-Q 2024-10-30
2022 $115M -$10K -0.01% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $115M +$8.38M +7.87% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $107M +$17.9M +20.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $88.6M +$8.56M +10.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $80M +$24.4M +43.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $55.6M +$15.7M +39.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $39.9M +$19.3M +93.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $20.6M +$10.6M +105% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $10M +$3.02M +43.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 $7.01M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.